News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Take-Two Interactive (TTWO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this publisher of …
Sharemaestro market context Trend signal active 52 weeks -2.8%Keros Therapeutics, Inc. LEXINGTON, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of …
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) said its first-quarter fiscal 2026 results were in line with its full-year outlook as growth from core brands and newer products largely offset expected declines in its mature portfolio. Revenue …
Takeda Pharmaceutical reported Q1 2026 results indicating steady growth, with revenue reaching JPY 1.22 trillion, a 10.2% increase at actual exchange rates, though declining 0.5% at constant currency. Despite core EPS falling due to prior-year tax benefits, the company maintained its full-year guidance and …
Takeda Pharmaceutical Company Limited reported consolidated IFRS results for Q1 2026, with revenue reaching ¥1.22 trillion, a 10.2% year-on-year increase primarily due to Japanese yen depreciation. Despite increased revenue and operating profit, net profit attributable to owners declined by 8.9% to ¥113.2 billion, resulting …
Amundi increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 38.1% in the first quarter, now owning 1.35% of the company's stock valued at $492.56 million. Other institutional investors have also adjusted their holdings, while insiders have sold a significant amount of shares. Analysts …
Solid first quarter performance broadly in line with guidance, underpinned by resilient demand across core in-line brands Commercial execution and late-stage pipeline investments on schedule, including first approval for ORZEYFULTM (oveporexton) in China, setting the foundation for next wave of medicines No change to …
At its September 17, 2026 Annual Meeting, Take-Two Interactive Software proposed amending its Restated Certificate of Incorporation to limit certain officers' liability in line with Delaware law, mainly shielding them from monetary damages in direct shareholder suits while retaining accountability for loyalty breaches and …
Sharemaestro market context Trend signal active 52 weeks -2.8%Karnataka officials held discussions with Takeda Pharmaceutical leaders regarding the expansion of their Global Capability Centre (GCC) in Bengaluru. The talks focused on leveraging Karnataka's strong biotechnology and medtech ecosystems for digital transformation, research, and product development, including AI-driven drug discovery. Karnataka pledged continued …
Lazard Asset Management LLC significantly increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 111.1% in the first quarter, now owning 213,026 shares valued at $42.1 million. Other institutional investors like Norges Bank and AQR Capital also expanded their positions, bringing institutional ownership to …
First Trust Advisors LP increased its stake in Take-Two Interactive Software, Inc. by 57.3% in the first quarter, purchasing an additional 46,766 shares to own a total of 128,452 shares valued at $25.37 million. This move is part of broader institutional investor activity, with …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Take-Two Interactive Software (TTWO) has put a proposed Officer Exculpation Amendment on the agenda for its September 17, 2026 shareholder meeting, focusing on …
Sharemaestro market context Trend signal active 52 weeks -2.8%This article provides a comprehensive stock analysis of Take-Two Interactive Software Inc (TTWO) by TradingKey, highlighting its healthy fundamentals, significant growth potential, and "fairly valued" status within the Software & IT Services industry. The stock has high institutional ownership and analyst ratings indicating a …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Take-Two Interactive Software (NasdaqGS:TTWO) has proposed an Officer Exculpation Amendment to its Restated Certificate of Incorporation. The amendment would limit the liability of certain officers to the …
Sharemaestro market context Trend signal active 52 weeks -2.8%Take-Two Interactive (TTWO) saw a 1.5% increase in its stock price, outperforming the S&P 500's daily gain. Despite a recent monthly decline, the company is expected to report earnings on August 7, 2026, with revenue predicted to decrease year-over-year. Analysts' positive revisions and a …
Sharemaestro market context Trend signal active 52 weeks -2.8%Take-Two Interactive's Chief Legal Officer maintained a compensation of nearly $8 million for the 2026 fiscal year, according to recent securities filings. This report from Law360 Pulse highlights the legal leader's steady earnings. The full article content is behind a paywall, requiring a free …
Takeda Pharmaceutical Company Limited's average 12-month price target has been increased to $19.2, representing a potential 10% upside from its July 27 closing price. This revised target is based on estimates from 13 analysts, with forecasts ranging from $17.27 to $21.28 per share. The …
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …
Sharemaestro market context Trend signal active 52 weeks -2.8%SBI Securities initiated coverage on Takeda Pharmaceutical (4502.FU) with a Neutral rating and a price target of 5,400 yen. The Japanese pharmaceutical company's stock was trading at 5,744.00 JPY, down 0.43% for the day, as of the market close. The report from MT Newswires …
Take-Two Interactive Software (TTWO) is proposing an amendment to its Certificate of Incorporation to limit certain officer liability, aligning with recent changes in Delaware corporate law. This "Officer Exculpation Amendment" would affect how direct shareholder claims are brought against executives, excluding breaches of loyalty …
Take-Two Interactive Software Inc (TTWO) stock rose 5.3% to $243.95, but GuruFocus's GF Value™ indicates it is 13.6% overvalued at $214.75. The stock has a GF Score™ of 77/100, suggesting above-average quality, yet insiders have sold $135.3 million worth of shares in the last …
Sharemaestro market context Trend signal active 52 weeks +3.8% · Next-week setup positive 55.5%Takeda Pharmaceutical stock has returned 91.4% over the past 5 years and appears undervalued on market multiples, yet broader valuation checks are mixed. The company's P/S ratio of 2.0x is below the model-based fair ratio of 3.4x, suggesting it's undervalued on sales despite recent …
Sharemaestro market context Price above Trend Line 52 weeks +27.3%Takeda Pharmaceutical (TSE:4502) has released positive Phase 3 data for its oral TYK2 inhibitor zasocitinib for plaque psoriasis, which has contributed to recent share price momentum. Despite this, the stock trades below analyst price targets and some intrinsic value estimates, suggesting it may be …
Sharemaestro market context Price above Trend Line 52 weeks +27.3%Take-Two Interactive has projected fiscal 2027 net bookings to reach $8.0 billion to $8.2 billion, a 20% increase directly attributed to the confirmed November 19 launch of Grand Theft Auto VI. This guidance has led to a significant re-evaluation of Take-Two stock, with TIKR's …
BTIG Research has reaffirmed its "buy" rating for Take-Two Interactive Software (NASDAQ:TTWO), setting a price target of $293, which suggests a 26.48% upside. The consensus among analysts is a "Moderate Buy" with an average price target of $294.44. Insider trading activity shows significant sales, …
Sharemaestro market context Trend signal active 52 weeks -2.8%SummitTX Capital L.P. decreased its stake in Take-Two Interactive Software by 20.7% in the first quarter, selling 11,261 shares and retaining 43,165 shares valued at approximately $8.5 million. Meanwhile, institutional investors collectively own 95.46% of the company's stock, while insiders have sold a significant …
Delta Global Management LP significantly increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by over 600% in the first quarter, according to a recent SEC filing. The company's stock performance and valuations are detailed, alongside analyst ratings which generally recommend a "Moderate Buy". …
This article from OpenSecrets details the lobbying activities of Takeda Pharmaceutical Co in 2025. It lists the 30 lobbyists hired by the company, including information on their firms and whether they previously worked in the federal government. The report indicates that 19 of the …
In July 2026, Takeda announced new Phase 3 data for its oral TYK2 inhibitor zasocitinib (TAK-279) in adults with moderate-to-severe plaque psoriasis, showing consistently high rates of skin clearance across difficult areas such as the scalp, nails, palms and soles compared with placebo. The …
Tiger Global Management LLC significantly reduced its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 65.7% in the first quarter, yet still holds 2 million shares valued at approximately $395 million. Despite this reduction, institutional ownership remains very high at 95.46%, with major investors like …
Epoch Investment Partners Inc. has reduced its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 27.0%, selling 31,192 shares in the first quarter, bringing their total holdings to 84,344 shares valued at $16.66 million. This comes amidst other institutional investor activities and significant insider …
Caxton Associates LLP significantly reduced its stake in Take-Two Interactive Software (NASDAQ:TTWO) in the first quarter, selling 13,077 shares and ending the period with 7,211 shares valued at approximately $1.42 million. Several company insiders, including President Karl Slatoff and Daniel P. Emerson, also sold …
Allspring Global Investments Holdings LLC significantly reduced its stake in Take-Two Interactive Software (NASDAQ:TTWO) by selling 110,083 shares, decreasing its ownership by 92.0% in the first quarter. Despite this, other institutional investors have recently bought shares, and analysts maintain a "Moderate Buy" consensus rating …
Search by ticker symbol or company name and select a result to open its chart.